| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |